Kainos Medicine Inc (284620) — Financial Flexibility Index
Kainos Medicine Inc (284620) has a Financial Flexibility Index of -0.37x as of March 2025. Free cash flow of ₩-2.93 Billion (operating CF ₩-2.97 Billion minus capex ₩40.29 Million) represents 0% of total liabilities (₩7.97 Billion). Check 284620 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kainos Medicine Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Kainos Medicine Inc across 8 annual periods. For the full cash flow conversion analysis, see 284620 cash generation efficiency.
Annual Financial Flexibility Index for Kainos Medicine Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Kainos Medicine Inc. Explore Kainos Medicine Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.06x | ₩-9.50 Billion | ₩-9.71 Billion | ₩8.95 Billion | ▲ +3.2% |
| 2023 | -1.10x | ₩-10.12 Billion | ₩-14.22 Billion | ₩9.23 Billion | ▼ -59.8% |
| 2022 | -0.69x | ₩-8.83 Billion | ₩-11.30 Billion | ₩12.87 Billion | ▼ -201.2% |
| 2021 | -0.23x | ₩-6.80 Billion | ₩-9.20 Billion | ₩29.85 Billion | ▲ +20.0% |
| 2020 | -0.28x | ₩-6.39 Billion | ₩-7.61 Billion | ₩22.43 Billion | ▼ -221.1% |
| 2019 | 0.24x | ₩185.74 Million | ₩185.74 Million | ₩789.89 Million | ▲ +924.8% |
| 2018 | -0.03x | ₩-22.01 Million | ₩-22.01 Million | ₩772.06 Million | ▲ +22.5% |
| 2017 | -0.04x | ₩-27.23 Million | ₩-27.23 Million | ₩740.19 Million | — |